GENinCode plc

Company Profile

Company website
Medical Equipment and Services (Medical Services)
GENinCode plc (AIM: GENI) is engaged in the risk assessment, prediction and prevention of cardiovascular disease (“CVD”). CVD is the leading cause of death worldwide accounting for approximately 18 million deaths annually.

Investor Access

27 Sep
Event information
Management will hold a presentation for Investors through the digital platform, Investor Meet Company, on Tuesday 27th September 2022 at 4:30pm (BST) relating to the interim results for the six months ended 30 June 2022.  Investors can sign up to Investor Meet Company for free, by clicking here.
Tuesday 27th September 2022 at 4:30pm (BST)
Financial Calendar
 Event Date
Year EndDecember 31
Half  Year End30 June
Preliminary Results*March/April
Interim Results*September

* Months based on previous announcements of this kind